Owens David 4
4 · Nexalin Technology, Inc. · Filed Sep 12, 2025
Insider Transaction Report
Form 4
Owens David
DirectorChief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2025-09-12+100,000→ 1,484,809 totalExercise: $0.96From: 2025-09-12Exp: 2030-08-29→ Common Stock (100,000 underlying) - Award
Stock Option (right to buy)
2025-09-12+203,125→ 1,384,809 totalExercise: $0.96From: 2025-09-12Exp: 2030-08-29→ Common Stock (203,125 underlying)